Takeda Pharmaceutical Company Limited TAK

$ 16.68 0.6%

Quarterly report 2025-Q1
added 05-13-2026

Takeda Pharmaceutical Company Limited DIO Ratio 2011-2026 | TAK

Annual DIO Ratio Takeda Pharmaceutical Company Limited

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	254	546	157	148	173	184	189	187	164	158

All numbers in JPY currency

Indicator range from annual reports

Maximum	Minimum	Average
546	148	216

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	FSD Pharma HUGE	174	-	5743.5 %	$ 69.7 M	Canada
	Happiness Biotech Group Limited HAPP	1.91 K	-	1.35 %	$ 17.8 M	China
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain
	Esperion Therapeutics ESPR	2.46 K	$ 3.13	-	$ 651 M	USA
	Eton Pharmaceuticals ETON	150	$ 34.45	4.74 %	$ 927 M	USA
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Grifols, S.A. GRFS	0.000171	$ 8.19	4.46 %	$ 5.57 B	Spain
	Berkeley Lights BLI	246	-	-7.31 %	$ 87 M	USA
	Autolus Therapeutics plc AUTL	70.7	$ 1.62	-0.61 %	$ 431 M	Britain
	Cyclacel Pharmaceuticals CYCCP	185	-	-4.36 %	$ 27 M	USA
	Anika Therapeutics ANIK	159	$ 15.14	2.16 %	$ 217 M	USA
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Incyte Corporation INCY	78.4	$ 97.08	1.55 %	$ 19 B	USA
	Coherus BioSciences CHRS	97.5	$ 1.51	2.03 %	$ 177 M	USA
	Albireo Pharma ALBO	26.1	-	-0.23 %	$ 916 M	USA
	Arcutis Biotherapeutics ARQT	185	$ 20.47	4.97 %	$ 2.6 B	USA